Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prions and the proteasome.

Pelagia Deriziotis1, Sarah J Tabrizi

  • 1Department of Neurodegenerative Disease, Institute of Neurology, University College London, London, WC1N 3BG, UK.

Biochimica Et Biophysica Acta
|July 23, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic or pharmacological disruption of the MSH3 Y245/K246 IDL binding pocket slows CAG repeat expansion.

NAR molecular medicine·2026
Same author

Targeting toxic HTT1a could be the key to treating Huntington disease.

Nature reviews. Neurology·2026
Same author

Shape matters: Predicting Huntington's disease using progression modelling.

Computer methods and programs in biomedicine·2026
Same author

Discovery of disrupted sustained attention and altered functional connectivity in far-from-onset Huntington's disease gene-expanded young adults.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Oral splicing modulator branaplam in Huntington's disease: a phase 2 randomized controlled trial.

Nature medicine·2026
Same author

Mapping Regional Brain Aging in Huntington's Disease Using Structural Magnetic Resonance Imaging and Machine Learning.

Movement disorders : official journal of the Movement Disorder Society·2025
Same journal

Cumulative Contents.

Biochimica et biophysica acta·2020
Same journal

Molecular Basis of Disease Cumulative Contents.

Biochimica et biophysica acta·2020
Same journal

General Subjects Cumulative Contents.

Biochimica et biophysica acta·2020
Same journal

Erratum to 'on the role of exchangeable hydrogen bonds for the kinetics of P680<sup>+·</sup> Q<sub>A</sub> <sup>-·</sup> formation and P680<sup>+·</sup> Pheo<sup>-·</sup> recombination in photosystem II' [Biochim. Biophys. Acta 1276 (1996) 35-44].

Biochimica et biophysica acta·2019
Same journal

Oligomeric state of the light-harvesting complexes B800-850 and B875 from purple bacterium Rubrivivax gelatinosus in detergent solution.

Biochimica et biophysica acta·2019
Same journal

Regulation of pigment content and enzyme activity in the cyanobacterium Nostoc sp. Mac grown in continuous light, a light-dark photoperiod, or darkness.

Biochimica et biophysica acta·2019
See all related articles

Prion diseases involve misfolded prion proteins (PrPSc) causing neurodegeneration. This review explores how the ubiquitin proteasome system (UPS) may be involved in prion disease pathogenesis.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Protein Biochemistry

Background:

  • Prion diseases are fatal neurodegenerative conditions affecting humans and animals.
  • They stem from the misfolding of the host prion protein (PrPC) into an abnormal, infectious isoform (PrPSc).
  • The exact mechanisms driving neuronal death in prion diseases are not fully understood.

Purpose of the Study:

  • To review the potential interactions between prions and the ubiquitin proteasome system (UPS).
  • To outline the possible role of the UPS in prion-mediated neurodegeneration.

Main Methods:

  • Review of existing scientific literature on prion diseases and the UPS.
  • Analysis of studies investigating PrP interactions with proteasome function.
  • Examination of cellular accumulation of PrP isoforms following proteasome inhibition.

Related Experiment Videos

Main Results:

  • Both normal (PrPC) and disease-associated (PrPSc) prion proteins accumulate in cells when the proteasome is inhibited.
  • Abnormal, beta-sheet-rich PrP isoforms can inhibit the catalytic activity of the proteasome.
  • Evidence suggests a significant role for the UPS in cellular responses to prion protein.

Conclusions:

  • The ubiquitin proteasome system (UPS) is increasingly implicated in the pathogenesis of prion diseases.
  • Dysfunction of the UPS may contribute to the accumulation of toxic prion protein species and subsequent neurodegeneration.
  • Further research into the prion-proteasome interaction is crucial for understanding and potentially treating these devastating disorders.